|
KDM3A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.43249994883399E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.28189999965601E-07 |
| Normal-vs-Stage2 |
2.38299999999469E-06 |
| Normal-vs-Stage3 |
1.93149999994091E-07 |
| Normal-vs-Stage4 |
3.80709999969753E-07 |
| Stage1-vs-Stage2 |
1.559040E-01 |
| Stage1-vs-Stage3 |
1.621950E-01 |
| Stage1-vs-Stage4 |
1.118600E-01 |
| Stage2-vs-Stage3 |
7.304800E-01 |
| Stage2-vs-Stage4 |
8.550200E-01 |
| Stage3-vs-Stage4 |
8.421000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.26290000071572E-08 |
| Normal-vs-AfricanAmerican |
5.633700E-02 |
| Normal-vs-Asian |
5.86559999999903E-05 |
| Caucasian-vs-AfricanAmerican |
1.379240E-01 |
| Caucasian-vs-Asian |
8.452400E-01 |
| AfricanAmerican-vs-Asian |
2.838800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.27210000053924E-07 |
| Normal-vs-Female |
1.69930000071261E-08 |
| Male-vs-Female |
6.402000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.3351999999921E-05 |
| Normal-vs-Age(41-60Yrs) |
2.8712999999847E-07 |
| Normal-vs-Age(61-80Yrs) |
2.3085999778516E-09 |
| Normal-vs-Age(81-100Yrs) |
4.682100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.068200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.128020E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.566200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.539000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.808800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.252200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.705800E-02 |
| Classical-VS-Follicular |
1.531800E-02 |
| Classical-VS-Other |
8.035000E-01 |
| Classical-VS-Normal |
1.33179999994848E-06 |
| Tall-VS-Follicular |
8.727400E-01 |
| Tall-VS-Other |
4.249600E-01 |
| Tall-VS-Normal |
8.24250000031057E-07 |
| Follicular-VS-Other |
5.757600E-01 |
| Follicular-VS-Normal |
3.26779999948457E-07 |
| Other-VS-Normal |
7.384100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.59090002177709E-09 |
| Normal-vs-N1 |
1.99770999999016E-05 |
| N0-vs-N1 |
7.964000E-01 |
|
|
